Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Bernhart, E; Damm, S; Heffeter, P; Wintersperger, A; Asslaber, M; Frank, S; Hammer, A; Strohmaier, H; DeVaney, T; Mrfka, M; Eder, H; Windpassinger, C; Ireson, CR; Mischel, PS; Berger, W; Sattler, W.
Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways.
Neuro Oncol. 2014; 16(7):933-945
Doi: 10.1093/neuonc/not303
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Bernhart Eva Maria
- Sattler Wolfgang
- Co-authors Med Uni Graz
- Asslaber Martin
- Damm Sabine
- DeVaney Trevor
- Eder Hans
- Frank Sasa
- Hammer Astrid
- Mrfka Manuel
- Strohmaier Heimo
- Windpassinger Christian
- Wintersperger Andrea
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Glioblastoma multiforme (GBM) is a highly aggressive tumor of the central nervous system with a dismal prognosis for affected patients. Aberrant protein kinase C (PKC) signaling has been implicated in gliomagenesis, and a member of the PKC-activated protein kinase D (PRKD) family, PRKD2, was identified as mediator of GBM growth in vitro and in vivo. The outcome of PRKD2 silencing and pharmacological inhibition on glioma cell proliferation was established with different glioma cell lines. Western blotting, senescence assays, co-immunoprecipitation, fluorescence activated cell sorting, quantitative PCR, and immunofluorescence microscopy were utilized to analyze downstream signaling. RNA-interference (21-mer siRNA) and pharmacological inhibition (CRT0066101) of PRKD2 profoundly inhibited proliferation of p53(wt) (U87MG, A172, and primary GBM2), and p53(mut) (GM133, T98G, U251, and primary Gli25) glioma cells. In a xenograft experiment, PRKD2 silencing significantly delayed tumor growth of U87MG cells. PRKD2 silencing in p53(wt) and p53(mut) cells was associated with typical hallmarks of senescence and cell cycle arrest in G1. Attenuated AKT/PKB phosphorylation in response to PRKD2 silencing was a common observation made in p53(wt) and p53(mut) GBM cells. PRKD2 knockdown in p53(wt) cells induced upregulation of p53, p21, and p27 expression, decreased phosphorylation of CDK2 and/or CDK4, hypophosphorylation of retinoblastoma protein (pRb), and reduced transcription of E2F1. In p53(mut) GM133 and primary Gli25 cells, PRKD2 silencing increased p27 and p15 and reduced E2F1 transcription but did not affect pRb phosphorylation. PRKD2 silencing induces glioma cell senescence via p53-dependent and -independent pathways.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Blotting, Western -
- Brain Neoplasms - metabolism
- Cell Line, Tumor -
- Cellular Senescence - physiology
- Flow Cytometry -
- Gene Silencing -
- Glioma - metabolism
- Heterografts -
- Humans -
- Immunoprecipitation -
- Mice -
- Microscopy, Fluorescence -
- Protein Kinases - metabolism
- RNA Interference -
- Real-Time Polymerase Chain Reaction -
- Signal Transduction - physiology
- Transfection -
- Tumor Suppressor Protein p53 - metabolism
- Find related publications in this database (Keywords)
- glioblastoma multiforme
- protein kinase D2
- p53
- senescence
- xenograft